Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Claritas Pharmaceuticals Inc (CLASh)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.0250 0.0000    0.00%
19/07 - Delayed Data. Currency in CAD ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 0.0250 / 0.0350
  • Day's Range: 0.0250 - 0.0250
Type:  Equity
Market:  Canada
Claritas Pharmaceuticals 0.0250 0.0000 0.00%

Claritas Pharmaceuticals Inc Company Profile

 
Get an in-depth profile of Claritas Pharmaceuticals Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

-

Equity Type

ORD

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

Contact Information

Address 4040 Civic Center Drive Suite 200
San Rafael, 94903
United States
Phone -
Fax -

Top Executives

Name Age Since Title
Stuart L. Silverman 75 2015 Co-Chair of Scientific Advisory Board and Vice President of Medical Affairs
Robert Farrell - 2016 Chairman, CEO & President
Li Zhang - 2018 Member of Strategic & Scientific Advisory Board
Perenlei Enkhbaatar - 2021 Independent Director
Yong-Hui Jiang - - Member of Scientific Advisory Board
Deborah Kado - - Member of Scientific Advisory Board
Robert S. Langer 74 2016 Member of Scientific Advisory Board
Salvatore Cuzzocrea - 2021 Independent Director
Yossi Tam - - Member of Scientific Advisory Board
Hanns Ulrich Zeilhofer - 2018 Member of Strategic & Scientific Advisory Board
Garry J. Southan - 2021 Member of Scientific Advisory Board
Joseph Lynch - 2018 Member of Strategic & Scientific Advisory Board
Yanekl Gabet - - Member of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CLASh Comments

Write your thoughts about Claritas Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Pari Canada
Pari Canada Dec 22, 2021 19:18
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Going up👍
van city
van city Apr 15, 2021 10:19
Saved. See Saved Items.
This comment has already been saved in your Saved Items
lame
Jessey Leonard
Jessey Leonard Apr 15, 2021 10:19
Saved. See Saved Items.
This comment has already been saved in your Saved Items
You’ll regret that position
Jonathan Guindon
Jonathan Guindon Mar 02, 2021 12:03
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Big potential?
Garrett Grosvenor
Garrett Grosvenor Mar 01, 2021 14:25
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Going up👍
Sonny Fakhri
Sonny Fakhri Mar 01, 2021 10:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This is going up 🔥
David Bredin
David Bredin Feb 28, 2021 19:17
Saved. See Saved Items.
This comment has already been saved in your Saved Items
🚀
harkanwal mangat
harkanwal mangat Feb 26, 2021 10:21
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Very soon going to shoot
Temagami Mike
Temagami Mike Feb 05, 2021 16:07
Saved. See Saved Items.
This comment has already been saved in your Saved Items
anyone??? no why this stock took off today
Bien Cardona
Bien Cardona Sep 25, 2020 18:02
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Salzman group?!? Was this finalized!!!
Joshua Chandler
Joshua Chandler Jul 12, 2020 11:05
Saved. See Saved Items.
This comment has already been saved in your Saved Items
most of the recent news releases have just reiterated same facts/findings with R-107.
Eric Perrier
Eric Perrier Jul 12, 2020 11:05
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hi! what do you think about a possible reversed split? they diluted many shares during the last years. I see a good potential with this cie but there a lot of things I don't understand either for exemple having troubles to find a partnership 😒 I have 700k at 0.05 $ shares and dont know if I would sell eventually. regards
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email